promyelocytic leukemia

Induction of differentiation on human promyelocytic leukemia cells by tadpole extract

蝌蚪提取液诱导人早幼粒白血病细胞分化的实验研究

Effects of Plumbagin on the Human Acute Promyelocytic Leukemia Cells In Vitro

白花丹醌对人急性早幼粒细胞白血病细胞的体外效应

Bcl 2 mRNA expression in acute promyelocytic leukemia by RT PCR

RT-PCR检测急性早幼粒白血病bcl-2mRNA表达

Improved RT-PCR for Detection of PML/ RAR α Fusion Gene in Rapid Diagnosis of Acute Promyelocytic Leukemia

改进的RT-PCR检测PML/RARα融合基因快速诊断急性早幼粒细胞白血病

Aim: To investigate the differentiation-inducing effect of α-anordrin ( ANO) on human promyelocytic leukemia HL-60 cells.

目的：研究α－双炔失碳酯（α－anordrin，ANO）对人早幼粒细胞白血病HL－60细胞的分化诱导作用。

Arsenic trioxide ( As_2O_3), as an anticancer drug for the treatment of acute promyelocytic leukemia ( APL), was approved by SDA of China in 1999 and by FDA of USA in 2000.Its mechanisms of chemotherapeutic effects were very complex.

三氧化二砷（As2O3）于1999年正式通过了国家药品监督管理局的审批，并于2000年9月25日作为治疗急性早幼粒细胞白血病（APL）的新药通过FDA的审批。

ATRA treatment induce terminal differentiation and growth arrest of several established human myeloid cell lines in vitro and has also proven to be effective in the clinical treatment of acute promyelocytic leukemia ( APL) by inducing differentiation and apoptosis of the immature blasts.

在体外一些髓样细胞系中ATRA可以诱导细胞周期阻滞及启动终末分化。并且由于它的这一特性已在临床用于治疗急性早幼粒细胞性白血病，并取得很好的疗效。

Objective To observe the clinical effects of all-trans-retinoic acid ( ATRA ) in treating 11 patients with acute promyelocytic leukemia ( APL ).

目的观察11例急性早幼粒细胞性白血病患者经全反式 维 甲酸 治疗后的临床效果.

Systemic review on progress of drug therapy for acute promyelocytic leukemia

急性早幼粒细胞白血病化疗的回顾及进展

Arsenous acid in treatment of relapsed acute promyelocytic leukemia

亚砷酸治疗复发急性早幼粒细胞白血病

Detection of PML/ RAR α Fusion Gene by a New Kind of Sandwich-type DNA Electrochemical Biosensor in Acute Promyelocytic Leukemia

新型三明治结构DNA电化学传感器对急性早幼粒细胞白血病相关融合基因的检测

Objective: To investigate the change of Hemophagocyte ( Hem) in patients with acute leukemia and anemia, and to explore its clinical significance in acute promyelocytic leukemia ( M 3).

目的：探讨急性白血病（AL）和贫血患者噬血细胞（Hem）变化，以阐明Hem在部分早幼粒细胞白血病（M3）出现的临床意义。

Observation and Nursing of Clinical Side Effects of Treatment of Acute Promyelocytic Leukemia in Arsenious Acid Injection

亚砷酸注射液治疗急性早幼粒细胞白血病副反应的观察与护理

Preliminary studies on the HPRT gene mutation of human promyelocytic leukemia cells induced by THH

昆明山海棠诱导人白血病细胞HPRT基因突变的研究

Clinical Analysis, Ultrastructural and Ultrastructural Cytochemical Studies of Acute Promyelocytic Leukemia

急性早幼粒细胞白血病临床分析和超微结构及超微细胞化学的研究

Coexistence of Tetrasomy 8 and Trisomy 8 in Acute Promyelocytic Leukemia ( AML-M_3) with t ( 15; 17)( q22; q12)

8号染色体四体、三体共存的t（15；17）（q22；q12）急性早幼粒细胞白血病（英文）

A Study on the Relationship between G-CSF and Acute Promyelocytic Leukemia

粒系集落刺激因子与急性早幼粒细胞白血病关系的研究

Arsenic has efficient cure effect on acute promyelocytic leukemia ( APL).

砷剂对急性早幼粒细胞白血病有良好的疗效，研究发现砷剂的作用机制可能包括：（1）诱导细胞凋亡和部分分化；

Clinical nursing care of 18 patients with acute promyelocytic leukemia treated with Tretinoin combined with Arsenious acid and a small dose of Daunorubicin

维甲酸联合亚砷酸、小剂量柔红霉素治疗急性早幼粒细胞白血病18例临床护理

The observation of the new sandwich TACE in treating massive hepatocellular carcinoma Detection of PML/ RAR α Fusion Gene by a New Kind of Sandwich-type DNA Electrochemical Biosensor in Acute Promyelocytic Leukemia

应用新三明治栓塞法治疗巨块型肝癌疗效观察新型三明治结构DNA电化学传感器对急性早幼粒细胞白血病相关融合基因的检测

Effect of sodium salicylate on human acute promyelocytic leukemia HL-60 cells

水杨酸钠对人早幼粒细胞白血病HL-60细胞的影响

Objective: To investigate the new maintenance chemotherapy of acute promyelocytic leukemia ( APL) after complete remission by all-trans retinoic acid ( ATRA), thereby increasing the long disease-free survival time of APL.

目的探索急性早幼粒细胞白血病（APL）经全反式维甲酸（ATRA）治疗达完全缓解（CR）后理想的维持治疗方案，提高APL的长期无病生存时间。

Clinical significance of acute promyelocytic leukemia with hemophagocytic hyperplasia

急性早幼粒细胞白血病伴噬血细胞增多的临床意义

Fortunately, these conditions are uncommon in patients with hematologic malignancies, with the exception of promyelocytic leukemia.

所幸的是, 除了早幼粒细胞白血病, 这种情况在恶性血液疾病患者中并不常见.

IntroductionAll-trans retinoic acid ( ATRA ) is efficiently differentiation in-ducer for acute promyelocytic leukemia ( APL ).

全反式维甲酸 ( ATRA ) 用于急性早幼粒细胞白血病 ( APL) 的诱导分化治疗,有很高的完全缓解(CR ) 率,现已成为APL诱导缓解治疗的首选药物.

Terminal Differentiation of Human Acute Promyelocytic Leukemia ( APL) Cells Induced by Tanshinone ⅱ A in Primary Culture

丹参酮ⅡA诱导原代培养人急性早幼粒细胞白血病细胞分化

Recent clinical studies show that arsenic trioxide ( As 2O 3) and arsenic tetrasulfide ( As 4S 4) are effective in the treatment to acute promyelocytic leukemia ( APL).

近年来临床研究表明，三氧化二砷（As2O3）和四硫化四砷（As4S4）对急性早幼粒细胞白血病有显著的疗效；

Tretinoin, the first successful differentiating agent, approed by FDA for use in acute promyelocytic leukemia.

FDA批准首个有效的促分化药物-维A酸治疗急性早幼粒细胞白血病.

Implication on differentiate diagnosis of acute promyelocytic leukemia by detection of PML/ RARa fusion gene

PML/RARa融合基因检测在早幼粒细胞性白血病鉴别诊断中的意义

Objective In a retrospective study, the clinical information of acute promyelocytic leukemia was analyzed. All the patients were in the Hematology Department, the first affiliated hospital of Guangxi Medical University.

目的分析广西医科大学第一附属医院血液内科治疗急性早幼粒细胞白血病（APL）患者的临床资料，评价治疗效果。